Research Project

Project Title:

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IGAN)

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Immune glomerulopathies

Project Summary:

To evaluate the effect of OMS721 in patients with IgA nephropathy (IgAN) onproteinuria assessed by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from baseline.

Lead principal investigator(s):

Loreto Gesualdo, Bari


F Annese, Bari
F Papadia, Bari

Project Period:

05/2022   -   04/2023




« Back to research page